Jarzab, Anna http://orcid.org/0000-0002-1059-9147
Kurzawa, Nils http://orcid.org/0000-0002-7846-2817
Hopf, Thomas
Moerch, Matthias
Zecha, Jana http://orcid.org/0000-0002-8767-6294
Leijten, Niels http://orcid.org/0000-0002-7305-7249
Bian, Yangyang
Musiol, Eva
Maschberger, Melanie
Stoehr, Gabriele
Becher, Isabelle http://orcid.org/0000-0001-7170-2235
Daly, Charlotte
Samaras, Patroklos http://orcid.org/0000-0001-6042-1585
Mergner, Julia
Spanier, Britta
Angelov, Angel http://orcid.org/0000-0002-9228-0817
Werner, Thilo
Bantscheff, Marcus http://orcid.org/0000-0002-8343-8977
Wilhelm, Mathias http://orcid.org/0000-0002-9224-3258
Klingenspor, Martin
Lemeer, Simone http://orcid.org/0000-0002-6230-9471
Liebl, Wolfgang
Hahne, Hannes http://orcid.org/0000-0003-3601-0051
Savitski, Mikhail M. http://orcid.org/0000-0003-2011-9247
Kuster, Bernhard http://orcid.org/0000-0002-9094-1677
Article History
Received: 2 July 2019
Accepted: 12 March 2020
First Online: 13 April 2020
Competing interests
: H.H. is cofounder, shareholder and CEO of OmicScouts GmbH. M.W. and B.K. are cofounders and shareholders of OmicScouts GmbH and msAId GmbH. M.W. and B.K. have no operational role in either company. T.W. and M.B. are employees and shareholders of GlaxoSmithKline. M.M.S. is a shareholder of GlaxoSmithKline.